Home / Compliance actions / 737549

FDA Warning Letter — Sanrace Biotechnology Co., Ltd.

Case 737549 — FEI 3016897521

The FDA took a Warning Letter action against Sanrace Biotechnology Co., Ltd. on Oct 22, 2026 (Jinhua, China). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Sanrace Biotechnology Co., Ltd.
Date
Oct 22, 2026
Fiscal Year
2027
Product Type
Drugs
Center
CDER
Location
Jinhua (China)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.